Aim immunotech inc signs material transfer and research agreement with japan's national institute of infectious diseases and shionogi

Aim immunotech inc - signs material transfer and research agreement with japan s national institute of infectious diseases and shionogi.aim immunotech inc - agreement to test ampligen as potential vaccine adjuvant for covid-19.aim immunotech inc - under agreement, aim will provide ampligen samples for various research projects.aim immunotech inc - details of all preclinical and clinical results will remain confidential until released by niid and shionogi.aim immunotech inc - this program will be a collaboration between niid and shionogi, with aim supplying ampligen.
AIM Ratings Summary
AIM Quant Ranking